AMGN vs NSPR · P/E 24, rev $10.05B vs rev $5.2M
Amgen Inc (AMGN) versus InspireMD Inc (NSPR) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
InspireMD Inc (NSPR) is a medical devices company listed on NASDAQ.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NSPR revenue for 2026-06-30 was $5.2M. Net income was -$28.0M. Revenue was up 52.1% from 2026-03-31 to 2026-06-30. NSPR currently screens at market cap $34.6M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NSPR currently screens at market cap $34.6M.
Not investment advice. Open the AMGN and NSPR stock pages for the full models.
Not investment advice.